BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 15000346)

  • 21. Microvascular coagulopathy and disseminated intravascular coagulation.
    ten Cate H; Schoenmakers SH; Franco R; Timmerman JJ; Groot AP; Spek CA; Reitsma PH
    Crit Care Med; 2001 Jul; 29(7 Suppl):S95-7; discussion S97-8. PubMed ID: 11445741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis and treatment of disseminated intravascular coagulation.
    Levi M
    Int J Lab Hematol; 2014 Jun; 36(3):228-36. PubMed ID: 24750668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of anticoagulant strategies on activation of inflammation and coagulation.
    Feistritzer C; Wiedermann CJ
    Expert Opin Biol Ther; 2007 Jun; 7(6):855-70. PubMed ID: 17555371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristic effects of activated human protein C on tissue thromboplastin-induced disseminated intravascular coagulation in rabbits.
    Katsuura Y; Aoki K; Tanabe H; Kiyoki M; Funatsu A
    Thromb Res; 1994 Nov; 76(4):353-62. PubMed ID: 7871494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of natural anticoagulants in the pathogenesis and management of systemic activation of coagulation and inflammation in critically ill patients.
    Levi M; van der Poll T
    Semin Thromb Hemost; 2008 Jul; 34(5):459-68. PubMed ID: 18956286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Possible involvement of cytokines in diffuse intravascular coagulation and thrombosis.
    Esmon CT
    Baillieres Best Pract Res Clin Haematol; 1999 Sep; 12(3):343-59. PubMed ID: 10856974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anticoagulant factor concentrates in disseminated intravascular coagulation: rationale for use and clinical experience.
    de Jonge E; van der Poll T; Kesecioglu J; Levi M
    Semin Thromb Hemost; 2001 Dec; 27(6):667-74. PubMed ID: 11740690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A short contemporary history of disseminated intravascular coagulation.
    Levi M; van der Poll T
    Semin Thromb Hemost; 2014 Nov; 40(8):874-80. PubMed ID: 25377321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of cancer-associated disseminated intravascular coagulation.
    Levi M
    Thromb Res; 2016 Apr; 140 Suppl 1():S66-70. PubMed ID: 27067981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coagulation and sepsis.
    Levi M; van der Poll T
    Thromb Res; 2017 Jan; 149():38-44. PubMed ID: 27886531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of fibrinolytic enzyme FIIa from Agkistrodon acutus venom on disseminated intravascular coagulation in rabbits.
    Lin X; Liang XX; Chen JS; Chen Q; Qiu PX; Yan GM
    Transl Res; 2007 Nov; 150(5):295-302. PubMed ID: 17964518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disseminated intravascular coagulation in sepsis.
    Zeerleder S; Hack CE; Wuillemin WA
    Chest; 2005 Oct; 128(4):2864-75. PubMed ID: 16236964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathophysiology, diagnosis and treatment of disseminated intravascular coagulation: an update.
    Franchini M
    Clin Lab; 2005; 51(11-12):633-9. PubMed ID: 16329621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coagulation inhibitors in sepsis and disseminated intravascular coagulation.
    Lee WL; Downey GP
    Intensive Care Med; 2000 Nov; 26(11):1701-6. PubMed ID: 11193281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of antithrombin on the systemic inflammatory response in disseminated intravascular coagulation.
    Nielsen JD
    Blood Coagul Fibrinolysis; 1998 Nov; 9 Suppl 3():S11-5. PubMed ID: 10102494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all-trans retinoic acid treatment.
    Dombret H; Scrobohaci ML; Ghorra P; Zini JM; Daniel MT; Castaigne S; Degos L
    Leukemia; 1993 Jan; 7(1):2-9. PubMed ID: 8418375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disseminated Intravascular Coagulation in Cancer: An Update.
    Levi M
    Semin Thromb Hemost; 2019 Jun; 45(4):342-347. PubMed ID: 31041800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Embelin ameliorated sepsis-induced disseminated intravascular coagulation intensities by simultaneously suppressing inflammation and thrombosis.
    Wang D; Yang Y; Wang Y; Proulle V; Andreasen PA; Hong W; Chen Z; Huang M; Xu P
    Biomed Pharmacother; 2020 Oct; 130():110528. PubMed ID: 32702634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The loss of homeostasis in hemostasis: new approaches in treating and understanding acute disseminated intravascular coagulation in critically ill patients.
    Hook KM; Abrams CS
    Clin Transl Sci; 2012 Feb; 5(1):85-92. PubMed ID: 22376264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disseminated intravascular coagulation in cancer patients.
    Levi M
    Best Pract Res Clin Haematol; 2009 Mar; 22(1):129-36. PubMed ID: 19285279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.